High-end European appliances on the horizon at new Houston store
BSH Home Appliances Experience & Design Center will open a Houston showroom in Post Oak Plaza, a property of Houston-based Levcor at 1703-1751 Post Oak Blvd. at San Felipe near the Galleria.
Scheduled to open in early 2023, the 14,847square-foot center with a Demo Kitchen and Prep Kitchen will offer home appliances and product demonstrations from brands Bosch, Thermador and Gaggenau.
“As an up-and-coming tech hub, Houston is an essential market for BSH to be located in and show off the latest in home appliance innovations,” Thomas Staebler, Head of Experience and Design Centers, North America, for BSH Home Appliances, said.
A subsidiary of Munich-based BSH Home Appliances Group, BSH Home Appliances Corp. produces and markets small and major home appliances across North America.
Katherine Feser
Fertitta’s hotel on ‘World’s Best’ list
The Post Oak Hotel at Uptown Houston, a property of Houston billionaire businessman and Rockets owner Tilman Fertitta, has received Travel + Leisure 2022 World’s Best Awards as the 13th Best City Hotel in the United States and the Best City Hotel in Houston.
The ultra-luxe 38story hotel, which opened at 1600 W. Loop South in 2018, was the only Texas hotel to make the list. The ranking is based on a reader survey developed by the editors of Travel + Leisure, a global travel brand and publication that also ranks top resort hotels, islands, cities, cruise lines, airlines and spas.
The 250-room hotel and spa, which caters to business and leisure travelers and has room rates starting at $649 to $799, recently earned the Forbes double-FiveStar rating for the second consecutive year.
Katherine Feser
Growth expected in biomanufacturing
The cell and gene therapy industry is set to have its highest annual number of regulatory approvals of new products, but limited biomanufacturing space means companies may not be able to produce enough supply to meet demand, according to an analysis from JLL, a global commercial real estate services company.
Nearly 600 clinical trials were initiated in 2021, according to Global Data, a data analytics and consulting company, headquartered in
London, up from about 500 in 2020.
Houston, a budding center for biomanufacturing, may be able to meet some of the demand to come.
The region offers lower costs and plenty of space to site manufacturing facilities while research at MD Anderson, Baylor College of Medicine and other institutions in the Texas Medical Center gives Houston a footprint in cell therapies, as do companies such as Immatics, a biotech company that develops cell therapies, and KBI Biopharma, a North Carolina biotech company that has a manufacturing location in Houston.
MD Anderson recently launched a joint venture with National Resilience, a San Diego-based biomanufacturer, to develop and manufacture cell therapies.
Rebecca Carballo